FdaApplication
ANDA 211618
Identifiers
- fda_app_no: ANDA211618
Properties
| Property | Value |
|---|---|
| applicant_name | VELZEN PHARMA PVT LTD |
| application_type | ANDA |
| approval_date | 2021-03-01 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DOXEPIN HYDROCHLORIDE | DOXEPIN HYDROCHLORIDE | EQ 150MG BASE | CAPSULE;ORAL |
1 product